Finance

Lists
STX:LON
Shield Therapeutics PLC
GBX 5.41
-2.48%
(-0.14) 1D
Sep 4, 4:30:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for STX...
Open
GBX 5.55
High
GBX 5.60
Low
GBX 5.40
Mkt. cap
58.85M
Avg. vol.
4.21M
Volume
1.48M
52-wk high
GBX 12.50
52-wk low
GBX 3.70
EPS
-GBX 0.01
Shares outstanding
1.07B
No. of employees
61
Open
GBX 5.55
High
GBX 5.60
Low
GBX 5.40
Mkt. cap
58.85M
Avg. vol.
4.21M
Volume
1.48M
52-wk high
GBX 12.50
52-wk low
GBX 3.70
EPS
-GBX 0.01
Shares outstanding
1.07B
No. of employees
61
About Shield Therapeutics PLC
CEOGreg Madison
Employees61
Founded2008
Headquarters-
SectorPharmaceutical industry
Websiteshieldtherapeutics.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.13M
14.13M
15.19M
15.19M
Cost of goods sold
7.90M
7.90M
6.13M
6.13M
Cost of revenue
7.90M
7.90M
6.13M
6.13M
Research and development expenses
399.00K
399.00K
468.00K
468.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.97M
7.97M
8.49M
8.49M
Operating expense
8.36M
8.36M
8.95M
8.95M
Total operating expenses
16.26M
16.26M
15.08M
15.08M
Operating income
-2.13M
-2.13M
104.50K
104.50K
Other non operating income
-1.50K
-1.50K
-
-
EBT including unusual items
-3.88M
-3.88M
-1.03M
-1.03M
EBT excluding unusual items
-3.97M
-3.97M
-1.03M
-1.03M
Income tax expense
178.00K
178.00K
99.50K
99.50K
Effective tax rate
-4.59%
-4.59%
-9.69%
-9.69%
Other operating expenses
-18.00K
-18.00K
-
-
Net income
-4.06M
-4.06M
-1.13M
-1.13M
Net profit margin
-28.74%
-28.74%
-7.42%
-7.42%
Earnings per share
-
-
-
-
Interest and investment income
-
-
5.00K
5.00K
Interest expense
-1.87M
-1.87M
-1.14M
-1.14M
Net interest expenses
-1.87M
-1.87M
-1.13M
-1.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.74M
-1.74M
155.00K
155.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps